Combination antihypertensive drugs: Recommendations for use

American Family Physician

Volumn 61, Issue 10, 2000, Pages 3049-3056

  Skolnik, Neil S ^a   Beck, Jonathan D ^a   Clark, Mathew ^a  

^a ABINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDACTAZINE; AMILORIDE; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMLODIPINE PLUS BENAZEPRIL; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; ATENOLOL PLUS CHLORTALIDONE; BENAZEPRIL; BENDROFLUMETHIAZIDE PLUS NADOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; CHLORTALIDONE; CHLORTALIDONE PLUS CLONIDINE; DILTIAZEM PLUS ENALAPRIL MALEATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENALAPRIL MALEATE PLUS FELODIPINE; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; HYDRALAZINE PLUS HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; HYDROCHLOROTHIAZIDE PLUS METHYLDOPA; HYDROCHLOROTHIAZIDE PLUS PROPRANOLOL; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; LISINOPRIL; LOSARTAN; METOPROLOL; METOPROLOL TARTRATE; MOEXIPRIL; NADOLOL; POLYTHIAZIDE PLUS PRAZOSIN; PROPRANOLOL; SPIRONOLACTONE; TIMOLIDE; TIMOLOL; TRANDOLAPRIL; TRANDOLAPRIL PLUS VERAPAMIL; TRIAMTERENE; UNCLASSIFIED DRUG; UNINDEXED DRUG; UNIRETIC; VALSARTAN; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BENZOTHIADIAZINES; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG COMBINATIONS; HUMANS; HYPERTENSION; LISINOPRIL; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 0034657439     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46 [Published erratum appears in Arch Intern Med 1998;158:573].
2. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and metaanalysis. JAMA 1997;277:739-45.
3. Burt VL, Culter JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9 [Published erratum appears in Hypertension 1996:27:1192].
4. Materson BJ, Reda DJ, Cushman WC, Massie BM, Preis ED, Kochar MS, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-21 [Published erratum appears in N Engl J Med 1994; 330:1689].
5. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990;150:1881-4
6. Sica DA. Fixed-dose combination antihypertensive drugs. Do they have a role in rational therapy? Drugs 1994;48:16-24.
7. Moser M, Prisant LM. Low-dose combination therapy in hypertension [Editorial]. Am Fam Physician 1997;56:1275-6, 1279, 1282.
8. Moser M. Current recommendations for initial therapy in hypertension: are they still valid? Introduction. Am J Hypertens 1998;11:69S-72S.
9. Moser M, Black HR. The role of combination therapy in the treatment of hypertension. Am J Hypertens 1998;11:73S-8S.
10. Drugs for hypertension. Med Lett Drugs Ther 1999; 41:23-8.
11. Neutel JM. Metabolic manifestations of low-dose diuretics. Am J Med 1996;101:71S-82S.
12. Hollenberg NK, Mickiewicz CW. Postmarketing surveillance in 70,898 patients treated with a triamterene/hydrochlorothiazide combination (Maxzide). Am J Cardiol 1989;63:37B-41B [Published erratum appears in Am J Cardiol 1990;66:388].
13. Cocke TB, Fisch S, Gilmore HR, Okun R, Tamagna IG, Wipplinger K. Double-blind comparison of triamterene plus hydrochlorothiazide and spironolactone plus hydrochlorothiazide in the treatment of hypertension. J Clin Pharmacol 1977;17:334-8.
14. Casner PR, Dillon KR. A comparison of the antihypertensive effectiveness of two triamterene/ hydrochlorothiazide combinations: Maxzide versus Dyazide. J Clin Pharmacol 1990;30:715-9.
15. Myers MG. Hydrochlorothiazide with or without amiloride for hypertension in the elderly. A dose-titration study. Arch Intern Med 1987;147:1026-30.
16. Jeunemaitre X, Charru A, Chatellier G, Degoulet P, Julien J, Plouin PF, et al. Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension Am J Cardiol 1988;62:1072-7.
17. Licht JG, Haley RJ, Pugh B, Lewis SB. Diuretic regimens in essential hypertension. A comparison of hypokalemic effects, BP control, and cost. Arch Intern Med 1983;143:1694-9.
18. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Multicenter Diuretic Cooperative Study Group. Arch Intern Med 1981;141:482-6.
19. Flack JM, Cushman WC. Evidence for the efficacy of low-dose diuretic monotherapy. Am J Med 1996;101:53S-60S.
20. Neutel JM, Black HR, Weber MA. Combination therapy with diuretics: an evolution of understanding. Am J Med 1996;101:61S-70S.
21. Frishman WH, Bryzinski BS, Coulson LR, DeQuattro VL, Vlachakis ND, Mroczek WJ, et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994;154:1461-8 [Published erratum appears in Arch Intern Med 1995;155:709].
22. Middlemost SJ, Tager R, Davis J, Sareli P. Effectiveness of enalapril in combination with low-dose hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients. Am J Cardiol 1994;73:1092-7.
23. Chrysant SG. Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. Arch Intern Med 1994;154:737-43.
24. Guul SJ, Os I, Jounela AJ. The efficacy and tolerability of enalapril in a formulation with a very low dose of hydrochlorothiazide in hypertensive patients resistant to enalapril monotherapy. Am J Hypertens 1995;8:727-31.
25. Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med 1990; 150:1175-83.
26. Cohn JN. The management of chronic heart failure. N Engl J Med 1996;335:490-8.
27. MacKay JH, Arcuri KE, Goldberg Al, Snapinn SM, Sweet CS. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components. Arch Intern Med 1996;156:278-85.
28. Hansson L, Himmelmann A. Calcium antagonists in antihypertensive therapy. J Cardiovasc Pharmacol 1991;18(suppl 10):S76-S80.
29. Gennari C, Nami R, Pavese G, Gragnani S, Bianchini C, Buracchi P. Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension. Cardiovasc Drugs Ther 1989;3(suppl 1):319-25.
30. DeQuattro V, Lee D. Fixed-dose combination therapy with trandolapril and verapamil SR is effective in primary hypertension. Trandolapril Study Group. Am J Hypertens 1997;10:138S-45S.
31. Gradman AH, Cutler NR, Davis PJ, Robbins JA, Weiss RJ, Wood BC. Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group. Am J Cardiol 1997;79:431-5.
32. Messerli F, Frishman WH, Elliott WJ. Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. Am J Hypertens 1998;11:322-7.
33. Mancia G, Omboni S, Grassi G. Combination treatment in hypertension: the VeraTran Study. Am J Hypertens 1997;10:1535-85.
34. Ruggenenti P, Remuzzi G. Primary prevention of renal failure in diabetic patients: the Bergamo Nephrologic Diabetes Complication Trial. J Hypertens Suppl 1998;16:S95-7.
35. Messerli F, Michalewicz L. Cardiac effects of combination therapy. Am J Hypertens 1997;10:146S-52S.
36. Weber MA. Translating data on antihypertensive drugs into clinical practice. Am J Hypertens 1998; 11:89S-94S.